Market Closed -
Nasdaq Stockholm
11:29:49 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
63.4
SEK
|
+1.93%
|
|
-0.86%
|
+20.53%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
7,419
|
6,148
|
5,715
|
4,161
|
4,711
|
5,678
|
-
|
-
|
Enterprise Value (EV)
1 |
15,336
|
14,524
|
15,536
|
14,879
|
15,450
|
16,202
|
15,701
|
14,527
|
P/E ratio
|
31.2
x
|
17.1
x
|
24.1
x
|
11.3
x
|
10.4
x
|
11.3
x
|
9.23
x
|
7.66
x
|
Yield
|
-
|
1.77%
|
1.9%
|
2.84%
|
2.38%
|
2.59%
|
3.14%
|
3.71%
|
Capitalization / Revenue
|
0.67
x
|
0.55
x
|
0.5
x
|
0.33
x
|
0.35
x
|
0.41
x
|
0.39
x
|
0.38
x
|
EV / Revenue
|
1.39
x
|
1.31
x
|
1.35
x
|
1.18
x
|
1.16
x
|
1.16
x
|
1.08
x
|
0.97
x
|
EV / EBITDA
|
10.2
x
|
8.73
x
|
8.66
x
|
7.28
x
|
6.78
x
|
6.62
x
|
6.07
x
|
5.33
x
|
EV / FCF
|
-8.8
x
|
12.5
x
|
13.6
x
|
10.3
x
|
9.47
x
|
11.3
x
|
10.1
x
|
8.78
x
|
FCF Yield
|
-11.4%
|
8.03%
|
7.33%
|
9.75%
|
10.6%
|
8.87%
|
9.86%
|
11.4%
|
Price to Book
|
1.84
x
|
1.42
x
|
1.26
x
|
0.89
x
|
0.96
x
|
1.08
x
|
0.99
x
|
0.89
x
|
Nbr of stocks (in thousands)
|
94,505
|
94,437
|
94,302
|
94,533
|
89,563
|
89,563
|
-
|
-
|
Reference price
2 |
78.50
|
65.10
|
60.60
|
44.02
|
52.60
|
63.40
|
63.40
|
63.40
|
Announcement Date
|
2/14/20
|
2/16/21
|
2/9/22
|
2/9/23
|
2/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
11,040
|
11,083
|
11,478
|
12,635
|
13,312
|
13,909
|
14,506
|
14,992
|
EBITDA
1 |
1,508
|
1,663
|
1,794
|
2,044
|
2,278
|
2,446
|
2,586
|
2,726
|
EBIT
1 |
525
|
717
|
743
|
843
|
981
|
1,092
|
1,195
|
1,333
|
Operating Margin
|
4.76%
|
6.47%
|
6.47%
|
6.67%
|
7.37%
|
7.85%
|
8.24%
|
8.89%
|
Earnings before Tax (EBT)
1 |
276
|
457
|
297
|
482
|
565
|
624.9
|
761.6
|
916.4
|
Net income
1 |
215
|
359
|
237
|
366
|
455
|
487.3
|
594.5
|
716.3
|
Net margin
|
1.95%
|
3.24%
|
2.06%
|
2.9%
|
3.42%
|
3.5%
|
4.1%
|
4.78%
|
EPS
2 |
2.520
|
3.800
|
2.510
|
3.890
|
5.070
|
5.605
|
6.868
|
8.274
|
Free Cash Flow
1 |
-1,743
|
1,166
|
1,139
|
1,451
|
1,631
|
1,438
|
1,548
|
1,656
|
FCF margin
|
-15.79%
|
10.52%
|
9.92%
|
11.48%
|
12.25%
|
10.33%
|
10.67%
|
11.04%
|
FCF Conversion (EBITDA)
|
-
|
70.11%
|
63.49%
|
70.99%
|
71.6%
|
58.78%
|
59.83%
|
60.72%
|
FCF Conversion (Net income)
|
-
|
324.79%
|
480.59%
|
396.45%
|
358.46%
|
295.02%
|
260.3%
|
231.1%
|
Dividend per Share
2 |
-
|
1.150
|
1.150
|
1.250
|
1.250
|
1.645
|
1.991
|
2.350
|
Announcement Date
|
2/14/20
|
2/16/21
|
2/9/22
|
2/9/23
|
2/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
2,912
|
2,988
|
3,080
|
3,143
|
3,187
|
3,225
|
3,235
|
3,310
|
3,355
|
3,412
|
3,424
|
3,479
|
3,460
|
3,538
|
3,530
|
EBITDA
1 |
578
|
492
|
451
|
511
|
634
|
447
|
510
|
485
|
693
|
591
|
564.5
|
550
|
724.5
|
607
|
572
|
EBIT
1 |
316
|
182
|
167
|
202
|
333
|
140
|
191
|
167
|
360
|
264
|
233.5
|
219.5
|
390
|
274.5
|
241
|
Operating Margin
|
10.85%
|
6.09%
|
5.42%
|
6.43%
|
10.45%
|
4.34%
|
5.9%
|
5.05%
|
10.73%
|
7.74%
|
6.82%
|
6.31%
|
11.27%
|
7.76%
|
6.83%
|
Earnings before Tax (EBT)
1 |
240
|
-49
|
83
|
117
|
249
|
33
|
89
|
59
|
261
|
157
|
114
|
99
|
270
|
158.5
|
126
|
Net income
1 |
190
|
-37
|
66
|
86
|
193
|
22
|
70
|
46
|
206
|
133
|
88
|
76.5
|
212
|
123.5
|
97
|
Net margin
|
6.52%
|
-1.24%
|
2.14%
|
2.74%
|
6.06%
|
0.68%
|
2.16%
|
1.39%
|
6.14%
|
3.9%
|
2.57%
|
2.2%
|
6.13%
|
3.49%
|
2.75%
|
EPS
2 |
2.010
|
-0.3900
|
0.7000
|
0.9100
|
2.040
|
0.2400
|
0.7700
|
0.5100
|
2.300
|
1.480
|
1.000
|
0.8850
|
2.450
|
1.425
|
1.120
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/4/21
|
2/9/22
|
5/4/22
|
8/18/22
|
11/3/22
|
2/9/23
|
5/4/23
|
8/17/23
|
11/2/23
|
2/8/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
7,917
|
8,376
|
9,821
|
10,718
|
10,739
|
10,524
|
10,023
|
8,849
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
5.25
x
|
5.037
x
|
5.474
x
|
5.244
x
|
4.714
x
|
4.303
x
|
3.875
x
|
3.246
x
|
Free Cash Flow
1 |
-1,743
|
1,166
|
1,139
|
1,451
|
1,631
|
1,438
|
1,548
|
1,656
|
ROE (net income / shareholders' equity)
|
6.4%
|
8.59%
|
5.35%
|
7.95%
|
9.48%
|
9.96%
|
11.5%
|
12.2%
|
ROA (Net income/ Total Assets)
|
2.19%
|
2.52%
|
1.51%
|
2.12%
|
2.54%
|
2.8%
|
3.42%
|
3.94%
|
Assets
1 |
9,817
|
14,264
|
15,696
|
17,275
|
17,884
|
17,384
|
17,396
|
18,198
|
Book Value Per Share
2 |
42.70
|
45.80
|
47.90
|
49.70
|
54.80
|
58.90
|
64.20
|
71.00
|
Cash Flow per Share
|
11.40
|
13.60
|
12.80
|
15.30
|
-
|
-
|
-
|
-
|
Capex
1 |
111
|
112
|
131
|
105
|
90
|
124
|
134
|
140
|
Capex / Sales
|
1.01%
|
1.01%
|
1.14%
|
0.83%
|
0.68%
|
0.89%
|
0.93%
|
0.94%
|
Announcement Date
|
2/14/20
|
2/16/21
|
2/9/22
|
2/9/23
|
2/8/24
|
-
|
-
|
-
|
Last Close Price
63.4
SEK Average target price
79.67
SEK Spread / Average Target +25.66% Consensus |
1st Jan change
|
Capi.
|
---|
| +20.53% | 518M | | -14.92% | 84.68B | | +13.30% | 81.12B | | +10.92% | 29.4B | | -12.71% | 16.73B | | -3.06% | 16.36B | | -2.63% | 14.92B | | -3.97% | 11.66B | | -1.42% | 11.72B | | -31.75% | 11.77B |
Other Healthcare Facilities & Services
|